Carbon Health hybrid clinic transition

Carbon Health’s revenue decline shows that the business is no longer being carried by one time Covid volume, and is now being judged on whether its core clinic network can grow like a real care delivery business. Revenue peaked at about $230M in 2021, then fell to $180M in 2022, $162M in 2023, rose slightly to $166M in 2024, and slipped again to $154M in 2025. That pattern fits a company replacing mass testing revenue with lower growth, steadier urgent and primary care visits.1 2

• The underlying model is hybrid care, not pure telehealth. Carbon runs physical clinics and an app based front door, so growth depends on clinic utilization, repeat visits, payer mix, and local density, not just adding more video consults. That makes it closer to a clinic operator with software than to a classic asset light telehealth company.2 3
• The financing history shows how much pandemic demand reshaped expectations. Carbon raised $350M at a $3.3B valuation in July 2021, then raised another $100M in January 2023 after the Covid boom had already faded. The 2023 financing kept the company funded through the reset, but the operating task had shifted from expansion to rebuilding a durable clinic level revenue base.2 4
• This arc mirrors a broader split in digital health. Pure telehealth can scale visits quickly but often has lower revenue per patient, while clinic led models can earn more per patient but grow slower because every market needs staffed locations. Carbon sits in the middle, using virtual visits to pull patients in, then routing higher value care into clinics.3 6

The next phase is about turning hybrid care from a pandemic expansion story into a denser, more repeatable local healthcare business. If Carbon can fill clinics with recurring urgent, primary, and payer driven visits instead of episodic testing demand, revenue should become less volatile and more tied to patient retention and market level execution.2 3